H. G. TAŞ Et Al. , "Potential Association of Favipiravir with Enhanced Ischemia/Reperfusion Injury in Rat Liver Tissue," ACTA FARMACEUTICA BONAERENSE , vol.432, no.10, pp.2169-2176, 2024
TAŞ, H. G. Et Al. 2024. Potential Association of Favipiravir with Enhanced Ischemia/Reperfusion Injury in Rat Liver Tissue. ACTA FARMACEUTICA BONAERENSE , vol.432, no.10 , 2169-2176.
TAŞ, H. G., TAŞ, N. G., KUYRUKLUYILDIZ, U., ZIRH, S., & KURT, N., (2024). Potential Association of Favipiravir with Enhanced Ischemia/Reperfusion Injury in Rat Liver Tissue. ACTA FARMACEUTICA BONAERENSE , vol.432, no.10, 2169-2176.
TAŞ, HAKAN Et Al. "Potential Association of Favipiravir with Enhanced Ischemia/Reperfusion Injury in Rat Liver Tissue," ACTA FARMACEUTICA BONAERENSE , vol.432, no.10, 2169-2176, 2024
TAŞ, HAKAN G. Et Al. "Potential Association of Favipiravir with Enhanced Ischemia/Reperfusion Injury in Rat Liver Tissue." ACTA FARMACEUTICA BONAERENSE , vol.432, no.10, pp.2169-2176, 2024
TAŞ, H. G. Et Al. (2024) . "Potential Association of Favipiravir with Enhanced Ischemia/Reperfusion Injury in Rat Liver Tissue." ACTA FARMACEUTICA BONAERENSE , vol.432, no.10, pp.2169-2176.
@article{article, author={HAKAN GÖKALP TAŞ Et Al. }, title={Potential Association of Favipiravir with Enhanced Ischemia/Reperfusion Injury in Rat Liver Tissue}, journal={ACTA FARMACEUTICA BONAERENSE}, year=2024, pages={2169-2176} }